Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 36 Advanced Solid Tumors 20 Myelodysplastic Syndromes 14 Breast Neoplasms 14 Carcinoma, Non-Small-Cell Lung 13 Advanced Solid Tumor 13 Recurrence 9 Ovarian Neoplasms 8 Neoplasms 8 Leukemia, Myelomonocytic, Chronic 8 Triple Negative Breast Neoplasms 7 Multiple Myeloma 7 Solid Tumor 6 Myeloproliferative Disorders 6 Prostatic Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, Large B-Cell, Diffuse 5 Lung Neoplasms 5 Carcinoma, Hepatocellular 5 Advanced Solid Tumour 5 Small Cell Lung Carcinoma 4 Sarcoma 4 Neoplasm Metastasis 4 Melanoma 4 Lymphoma, B-Cell 4 Fallopian Tube Neoplasms 4 Advanced Malignant Solid Tumor 4 Advanced Lung Cancer 4 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3

Interventions

pembrolizumab 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Solid Cancer × Injections × 1 year × Clear all

NCT07265921 2025-12-05

Solid Tumors

Jiangsu Simcere Pharmaceutical Co., Ltd.

Phase 1 Recruiting

Advanced Solid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡